Research Article

Network Pharmacology-Based Study on the Mechanism of Gegen Qinlian Decoction against Colorectal Cancer

Table 3

Information of 20 target genes in the pharmacological network.

GeneFull nameLog2FCAdjusted P valueAliases

PTGS2Prostaglandin G/H synthase 21.77697.39E − 03PGHS-2; COX-2; PHS-2; PGG/HS; hCox-2; GRIPGHS
OLR1Oxidized low-density lipoprotein receptor 11.99484.17E − 03LOX1; LOXIN; SLOX1; CLEC8A; SCARE1
NR3C2Nuclear receptor subfamily 3 group C member 2−1.51293.92E − 03MR; MCR; MLR; NR3C2VIT
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2−1.15928.47E − 03HSDB; HSD3B; SDR11E2
TNFSF15TNF superfamily member 151.04611.24E − 02TL1; TL1A; VEGI; TNLG1B; VEGI192A
MMP1Matrix metallopeptidase 13.23002.86E − 03CLG; CLGN
AKR1C3Aldo-keto reductase family 1 member C3−1.22676.79E − 03DD3; DDX; PGFS; HAKRB; HAKRe; HA1753; HSD17B5; hluPGFS
CA2Carbonic anhydrase 2−1.71849.85E − 03CAC; CAII; Car2; CAII; HEL-76; HEL-S-282
MMP3Matrix metallopeptidase 34.11011.41E − 03SL-1; STMY; STR1; CHDS6; MMP3; STMY1
PLAUPlasminogen activator, urokinase1.26424.83E − 03ATF; QPD; UPA; URK; u-PA; BDPLT5
MMP9Matrix metallopeptidase 91.12458.08E − 03GELB; CLG4B; MMP9; MANDP2
IL1BInterleukin 1 beta2.12392.27E − 03IL-1; IL1F2; IL1beta; IL1-BETA
DUOX2Dual oxidase 21.93282.98E − 02TDH6; LNOX2; THOX2; NOXEF2; P138-TOX
CCNB1Cyclin B11.02041.50E − 02CCNB
ABCG2ATP binding cassette subfamily G member 2−2.95212.92E − 03MRX; MXR; ABCP; BCRP; BMDP; MXR1; ABC15; BCRP1; CD338; GOUT1; MXR-1; CDw338; UAQTL1; EST157481
CXCL11C-X-C motif chemokine ligand 113.41222.12E − 03IP9; H174; IP-9; b-R1; I-TAC; SCYB11; SCYB9B
CXCL10C-X-C motif chemokine ligand 102.13226.06E − 03C7; IFI10; INP10; IP-10; crg-2; mob-1; SCYB10; gIP-10
SPP1Secreted phosphoprotein 11.50767.22E − 03OPN; BNSP; BSPI; ETA-1
ADH1CAlcohol dehydrogenase 1C (class I), gamma polypeptide−2.90477.54E − 03ADH3
MAOAMonoamine oxidase A−1.10457.88E − 03BRNRS; MAO-a

FC, fold change.